Anlotinib

  • CAT Number: I000298
  • CAS Number: 1058156-90-3
  • Molecular Formula: C23H22FN3O3
  • Molecular Weight: 407.44
  • Purity: ≥95%
Inquiry Now

Anlotinib (CAT: I000298) is an orally available small molecule that acts as an inhibitor of multiple receptor tyrosine kinases, including EGFR (epidermal growth factor receptor), VEGFR (vascular endothelial growth factor receptor), FGFR (fibroblast growth factor receptor), and PDGFR (platelet-derived growth factor receptor). It has shown promise as a targeted therapy for the treatment of non-small cell lung cancer (NSCLC). By inhibiting the activity of these kinases, Anlotinib can disrupt signaling pathways involved in tumor growth, angiogenesis, and metastasis. It has been investigated in clinical trials as a potential treatment option for various cancers, including NSCLC.

Catalog Number I000298
CAS Number 1058156-90-3
Molecular Formula

C23H22FN3O3

Purity 95%
Solubility DMSO: ≥ 44 mg/mL
Storage -20oC Freeze
Related CAS 1360460-82-7 (HCl salt)
InChI InChI=1S/C23H22FN3O3/c1-13-9-15-16(27-13)3-4-19(22(15)24)30-18-5-8-26-17-11-21(20(28-2)10-14(17)18)29-12-23(25)6-7-23/h3-5,8-11,27H,6-7,12,25H2,1-2H3
InChIKey KSMZEXLVHXZPEF-UHFFFAOYSA-N
SMILES CC1=CC2=C(N1)C=CC(=C2F)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC
Reference

<p>
[1]. PCT Int. Appl. (2015), WO 2015185012 A1 20151210. <br />
</p>

Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!